Peptide-lipid conjugates, liposomes and liposomal drug delivery

Details for Australian Patent Application No. 2005227364 (hide)

Owner The Liposome Company, Inc.

Inventors Franklin, J. Craig; Ali, Shaukat; Ahl, Patrick; Pak, Charles; Janoff, Andrew; Erukulla, Ravi; Meers, Paul; CabralLilly, Donna

Agent Allens Arthur Robinson

Pub. Number AU-A-2005227364

Parent 57355

Filing date 26 October 2005

Wipo publication date 24 November 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 009/127 Medicinal preparations characterised by special physical form - Liposomes

C12N 015/88 Mutation or genetic engineering

C12N 015/00 Mutation or genetic engineering

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

10 November 2005 Complete Application Filed

24 November 2005 Application Open to Public Inspection

  Published as AU-A-2005227364

6 April 2006 Assignment before Grant

  The Liposome Company, Inc The application has been assigned to Transave, Inc.

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227365-Novel compounds

2005227363-Bed System